🇺🇸 FDA
Pipeline program

PVSRIPO

Pro00085352

Phase 1 mab completed

Quick answer

PVSRIPO for Invasive Breast Cancer is a Phase 1 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Invasive Breast Cancer
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials